C07D 211/44
Attached in position 4
Official title: attached in position 4
C07D211/44 (Attached in position 4) appears on 1,802 US grants and 1,376 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,802
- Published applications
- 1,376
- Assignees
- 754
- Inventors
- 4,984
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 33 | 0 |
| 1977 | 44 | 0 |
| 1978 | 45 | 0 |
| 1979 | 25 | 0 |
| 1980 | 35 | 0 |
| 1981 | 34 | 0 |
| 1982 | 35 | 0 |
| 1983 | 35 | 0 |
| 1984 | 20 | 0 |
| 1985 | 36 | 0 |
| 1986 | 21 | 0 |
| 1987 | 18 | 0 |
| 1988 | 21 | 0 |
| 1989 | 17 | 0 |
| 1990 | 25 | 0 |
| 1991 | 26 | 0 |
| 1992 | 24 | 0 |
| 1993 | 40 | 0 |
| 1994 | 28 | 0 |
| 1995 | 33 | 0 |
| 1996 | 29 | 0 |
| 1997 | 44 | 0 |
| 1998 | 34 | 0 |
| 1999 | 38 | 0 |
| 2000 | 29 | 0 |
| 2001 | 31 | 8 |
| 2002 | 56 | 54 |
| 2003 | 49 | 74 |
| 2004 | 35 | 78 |
| 2005 | 53 | 78 |
| 2006 | 35 | 92 |
| 2007 | 37 | 79 |
| 2008 | 32 | 69 |
| 2009 | 68 | 74 |
| 2010 | 56 | 69 |
| 2011 | 47 | 65 |
| 2012 | 43 | 55 |
| 2013 | 59 | 48 |
| 2014 | 45 | 56 |
| 2015 | 54 | 48 |
| 2016 | 38 | 51 |
| 2017 | 50 | 54 |
| 2018 | 33 | 52 |
| 2019 | 43 | 39 |
| 2020 | 38 | 30 |
| 2021 | 28 | 33 |
| 2022 | 26 | 43 |
| 2023 | 25 | 42 |
| 2024 | 19 | 31 |
| 2025 | 21 | 35 |
| 2026 | 12 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Solid state forms of lucerastat and process for preparation thereof23 Jun 2026US 12,662,452 B2Assia Chemical Industries Ltd.
- Method for introducing deuterated lower alkyl into amine moiety of compound containing secondary amine19 May 2026US 12,630,487 B2Otsuka Pharmaceutical Co., Ltd.
- Opioid receptor agonist, preparation method therefor and pharmaceutical use thereof12 May 2026US 12,624,004 B2Fudan University
- Cobalt-catalyzed carbonylative alkene hydrofunctionalizations promoted by visible light8 Oct 2026US 2026/0308103 A1
- Flame retardant, composition, and molded article1 Oct 2026US 2026/0297296 A1Adeka Corporation
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- 1-deoxynojirimycin derivative and use thereof23 Jul 2026US 2026/0209177 A1Zhejiang University
- Lsd1 modulators23 Jul 2026US 2026/0209214 A1Recursion Pharmaceuticals, Inc.
Most cited
By later US patents
- Antidiabetic 3,4,5-trihydroxypiperidines252US 4,639,436 ABayer Aktiengesellschaft · 1987
- Cyclic amine compounds with activity against acetylcholinesterase174US 4,895,841 AEisai Co., Ltd. · 1990
- Sigma receptor ligands and the use thereof150US 6,057,371 AVirginia Commonwealth University · 2000
- Muscarinic receptor antagonists138US 6,693,202 B1Theravance, Inc. · 2004
- Urea derivatives and their use as ACAT inhibitors134US 5,621,010 ANisshin Flour Milling Co., Ltd. · 1997